Lahr, Germany

Stefan Gangkofner

This inventor holds 1 USPTO granted patent. Top assignees: Cu Chemie Uetikon Gmbh, Goedecke Aktiengesellschaft. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Gangkofner. Retrieved from https://idiyas.com/inventor/stefan-gangkofner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stefan Gangkofner

Introduction

Stefan Gangkofner is a notable inventor based in Lahr, Germany. He has made significant contributions to the field of chemistry, particularly in the area of pharmaceutical innovations. His work has led to the development of a patent that addresses important challenges in drug formulation.

Latest Patents

Stefan Gangkofner holds a patent for the racemic separation of ketamine. This innovation is crucial for enhancing the efficacy and safety of ketamine in medical applications. The patent showcases his expertise in chemical processes and his commitment to advancing pharmaceutical science. He has 1 patent to his name.

Career Highlights

Throughout his career, Gangkofner has worked with reputable companies, including Goedecke Aktiengesellschaft and Cu Chemie Uetikon GmbH. His experience in these organizations has allowed him to refine his skills and contribute to various projects in the chemical industry. His work has been instrumental in developing new methodologies and improving existing processes.

Collaborations

Stefan Gangkofner has collaborated with esteemed colleagues such as Klaus Steiner and Jean-Marie Grunenwald. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas. Their combined expertise has led to advancements in their respective fields.

Conclusion

Stefan Gangkofner is a distinguished inventor whose work in the racemic separation of ketamine has made a significant impact in the pharmaceutical industry. His collaborations and career experiences further highlight his contributions to innovation in chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…